Biofil Chemicals & Pharmaceuticals shareholding pattern
BIOFILCHEM
35.89
1.65 (-4.40%)Last updated on 6 Feb, 2026 | 15:57 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Biofil Chemicals & Pharmaceuticals reports the following shareholding: Total Promoters at 46.79%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0.08%, and Retail at 53.13%. This breakdown provides a quick snapshot of ownership distribution for Biofil Chemicals & Pharmaceuticals in 2025-26.
Biofil Chemicals & Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Biofil Chemicals & Pharmaceuticals stands at 46.79% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Biofil Chemicals & Pharmaceuticals is 0% and 0.08% respectively.
The retail shareholding of the Biofil Chemicals & Pharmaceuticals is 53.13%.
Changes in shareholding patterns of Biofil Chemicals & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Biofil Chemicals & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Biofil Chemicals & Pharmaceuticals Associated Pages
- Biofil Chemicals & Pharmaceuticals Share Price
- Biofil Chemicals & Pharmaceuticals Share Price chart
- Biofil Chemicals & Pharmaceuticals Fundamental Analysis
- Biofil Chemicals & Pharmaceuticals Technical Analysis
- Biofil Chemicals & Pharmaceuticals Peer Comparison
- Biofil Chemicals & Pharmaceuticals Share Price History
- Biofil Chemicals & Pharmaceuticals Board of Directors